Evidence map›Paper›PMID 25023623›Full record

ReviewCurrent opinion in HIV and AIDS2014

Distinctive features of CD4+ T cell dysfunction in chronic viral infections.

Antigoni Morou, Brent E Palmer, Daniel E Kaufmann

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in HIV and AIDS, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. IL-27 effects on HIVFrontiers in virology (Lausanne, Switzerland) · 2025
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Preterm Birth in Women With HIV: The Role of the Placenta.Frontiers in global women's health · 2022
    Review
  16. Article
  17. Chromatin Modifications in 22q11.2 Deletion Syndrome.Journal of clinical immunology · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Antigoni MorouaDepartement of Medicine and Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), University of Montreal, Montréal, Quebec, Canada bUniversity of Colorado, Research Complex 2, room 10007 (B164), 12700 E 19th Ave, Aurora, Colorado 80045 USA. cThe Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.
Brent E Palmer
Daniel E Kaufmann
Centre Hospitalier de l’Université de Montréal · CAGTx (United States) · USRagon Institute of MGH, MIT and Harvard · US

Funding

Support Component D/Vaccine Discovery, Concept to ClinicUM1AI100663 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI MCELRATH, MARGARET JULIANA · 2012 to 2018
$131.5M
Targeting the PD-1 signaling pathway to rescue HIV T cell dysfunctionP01AI080192 · NIAID · EMORY UNIVERSITY · PI AHMED, RAFI · 2008 to 2012
$12.6M
Alterations in Lung Microbiome in Acute and Chronic HIV infectionU01HL098996 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI FONTENOT, ANDREW P. · 2009 to 2013
$3.9M
Immunoregulatory networks and HIV pathogenesisR01HL092565 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI KAUFMANN, DANIEL E · 2007 to 2015
$3.4M
NHLBI NIH HHS R01 HL-092565NHLBI NIH HHS R01 HL092565NHLBI NIH HHS U01 HL098996NHLBI NIH HHS UO1 HL098996NHLBI NIH HHS UO1 HL13026NIAID NIH HHS P01 AI-080192NIAID NIH HHS P01 AI080192NIAID NIH HHS UM1 AI100663NIAID NIH HHS UM1AI100663
6 · The paper itself

Abstract

purpose of reviewTo describe recent advances in the understanding of virus-specific CD4 T cell dysfunction in chronic viral infections, with an emphasis on HIV disease. We highlight features that are distinctive for CD4 T cells, as opposed to their CD8 T cell counterparts. RECENT

findingsCD4 T cell activation and differentiation are tightly controlled. Regulation of these processes depends on the context of initial encounter of the naïve CD4 T cell with the cognate antigen and on ongoing external cues to the antigen-experienced CD4 T cell, in particular the inflammatory environment, which is prominent in HIV infection. Virus-specific CD4 T cell dysfunction results from a combination of an exhaustion program and skewing in T helper lineage differentiation which impact function. The CD4 and CD8 T cell exhaustion programs present similarities and distinct features. The sets of inhibitory coreceptors expression differ, although programmed-death 1 (PD-1) and T cell immunoglobulin mucin-3 (Tim-3) are upregulated on both HIV-specific CD4 and CD8 T cells, cytotoxic T-lymphocyte antigen 4 (CTLA-4) is largely specific to CD4 T cells, whereas 2B4 and CD160 are biased toward CD8 T cells. SUMMARY: Understanding the molecular basis of HIV-specific CD4 T cell exhaustion and identifying key differences with CD8 T cell impairment will be critical to design effective therapeutic and preventive immunotherapies against HIV.

Indexed as

CD4-Positive T-LymphocytesChronic DiseaseHIV InfectionsCD8-Positive T-LymphocytesHumansLymphocyte Activation

Identifiers

PMID25023623
PMCPMC4231289
OpenAlexW2318760048

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.